Abstract 405: (Z)-endoxifen modulates estrogen receptor and cell-cycle signaling to induce synergistic antiproliferative effects with CDK4/6 inhibition in endometrial cancer models.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Mayo Clinic, Atossa Therapeutics (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148890871
Cites:
Cited by:
Related to: